Literature DB >> 2432792

Antigen-specific suppressor T cells prevent cardiac injury in Balb/c mice infected with a nonmyocarditic variant of coxsackievirus group B, type 3.

M Estrin, C Smith, S Huber.   

Abstract

Two variants of coxsackievirus group B, Type 3 (CVB3o and CVB3M) infect Balb/c cardiac tissue equally, but only one variant (CVB3M) induces myocarditis. Various studies indicate that disease resistance in CVB3o-infected mice results from generation of suppressor cells. Low-dose cyclophosphamide (50 mg/kg body weight) treatment enhances inflammation in both CVB3M and CVB3o-infected animals, which clearly demonstrates that CVB3o has the capacity to induce disease, but inhibitory factors must exist preventing myocarditis. Spleen cells obtained from mice 10 days after CVB3o inoculation inhibited myocarditis induction in CVB3M-infected recipients, which confirms the presence of suppressor cells in these animals. The suppressor cell belongs to the Lyt 2+ subclass of T lymphocytes and specifically interferes with CVB3-induced myocarditis but fails to inhibit T-cell-mediated cardiac injury triggered by an unrelated virus, encephalomyocarditis virus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2432792      PMCID: PMC1888464     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  15 in total

1.  Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue.

Authors:  R E Paque; C J Gauntt; T J Nealon; M D Trousdale
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

Review 2.  Coxsackie viruses and the heart.

Authors:  N R Grist; E J Bell
Journal:  Am Heart J       Date:  1969-03       Impact factor: 4.749

3.  Suppressor cells in cyclophosphamide-treated autoimmune mice.

Authors:  E H Greeley; M Segre; D Segre
Journal:  Immunopharmacology       Date:  1982-08

Review 4.  Viral myocarditis. A review.

Authors:  J F Woodruff
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

5.  Demonstration of suppressor cells in coxsackievirus group B, type 3 infected female Balb/c mice which prevent myocarditis.

Authors:  L P Job; D C Lyden; S A Huber
Journal:  Cell Immunol       Date:  1986-03       Impact factor: 4.868

6.  Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice.

Authors:  C J Gauntt; M D Trousdale; D R LaBadie; R E Paque; T Nealon
Journal:  J Med Virol       Date:  1979       Impact factor: 2.327

7.  Hapten-specific IgE antibody responses in mice. VII. Conversion of IgE "non-responder" strains to IgE "responders" by elimination of suppressor T cell activity.

Authors:  N Chiorazzi; D A Fox; D H Katz
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

8.  Immune suppression with supraoptimal doses of antigen in contact sensitivity. I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide.

Authors:  M S Sy; S D Miller; H N Claman
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

9.  Differences in cytolytic T cell response of BALB/c mice infected with myocarditic and non-myocarditic strains of coxsackievirus group B, type 3.

Authors:  S A Huber; L P Job
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

10.  Separation of helper T cells from suppressor T cells expressing different Ly components. II. Activation by antigen: after immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses.

Authors:  H Cantor; F W Shen; E A Boyse
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

View more
  3 in total

1.  Protection against experimental autoimmune myocarditis is mediated by interleukin-10-producing T cells that are controlled by dendritic cells.

Authors:  Ya Li; Janet S Heuser; Stanley D Kosanke; Mark Hemric; Madeleine W Cunningham
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

2.  An attenuated variant of Coxsackievirus B3 preferentially induces immunoregulatory T cells in vivo.

Authors:  R P Loudon; A F Moraska; S A Huber; P Schwimmbeck; P Schultheiss
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

3.  Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2.

Authors:  S A Huber; J Polgar; P Schultheiss; P Schwimmbeck
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.